| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC0945 |
| Trial ID | ChiCTR2100050678 |
| Disease | B-Cell Malignancy |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19-mbIL15-CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti-CD19 Autologous CAR T-cells Produced by Rapid Personalized Manufacture (RPM CD19-mbIL15-CAR-T Cell Infusion) in Patients With Relapsed/Refractory B-cell Malignancies |
| Year | 2021 |
| Country | China |
| Company sponsor | Tongji Hospital of Tongji University |
| Cohort 1 | |||||||
|
|||||||